WSAVA bid to improve veterinary practice in oncology

WSAVA bid to improve veterinary practice in oncology

One in four dogs and one in five cats will develop cancer in their lifetime

Veterinary oncology has been given a global boost with the creation of a World Small Animal Veterinary Association Committee to raise awareness of the latest thinking on treatment and best practice.

With almost 50% of dogs aged over 10 developing cancer, the WSAVA Oncology Working Group’s team of experts will create practical, user-friendly tools for use by veterinarians to enhance standards of treatment and educate owners about cancer in pets.

It has also set about developing easy-to-use, accessible Global Guidelines for veterinary oncology practice.

Committee chair, Argentinian veterinarian and oncology specialist Dr. Martin Soberano, below, said: “The WSAVA Oncology Working Group aims to overcome global variations in oncology treatment and raise awareness of the different types of tumours affecting companion animals.

“Many cancers in these animals also occur in humans so we see an opportunity to improve the lives of both animal and human patients by raising standards of treatment for veterinary oncology patients.”

The other members are:

● Dr. Nick Bacon: A RCVS-Recognized Specialist in Small Animal Surgery (Oncology) and a European Specialist in Small Animal Surgery (Oncology), Dr. Bacon is Clinical Director, Oncologic & Soft Tissue Surgery at Fitzpatrick Referrals, UK

● Dr. Pachi Clemente-Vicario: A Diplomate in Oncology and Small Animal Internal Medicine from ACVIM, Dr. Clemente-Vicario works at La Merced Veterinary Oncology in Alicante, Spain

● Dr. Antonio Guiliano, Hong Kong: A Board-Certified Oncologist with ECVIM, Dr. Guiliano works at CityU VMC in Hong Kong as a Specialist in Oncology

●  Dr. Ann Hohenhaus: A Diplomate in Oncology and Small Animal Internal Medicine from ACVIM, Dr. Hohenhaus is Staff Doctor, Oncology, Animal Medical Center, New York, USA

● Dr. Natalia Ignatenko: Dr. Ignatenko completed her residency at the Department of Oncology Centre for Clinical Veterinary Medicine, LMU Munich, Germany, in 2017.

● Dr. Jolle Kirpensteijn, WSAVA Past President, past president of the Veterinary Society of Surgical Oncology, and avid international pet cancer advocate.

Dr. Felisbina Queiroga, a member of the WSAVA Executive Board with significant experience in oncology, will serve as Liaison between the Oncology Working Group and the Board.